Although both DIO and Sfrp1 loss exhibited effects on their own that could participate in an increased risk for cancer, the expression of Myc was enhanced by the two main effects together suggesting that a HFD and Sfrp1 loss, through methylation or mutation, could drive the expression of Myc to very high levels and thus work together to promote cancer risk. Here, MYC is linked to cancer.